DOJ Wants Teva Docs In Connection With FCPA Investigation
Law360, New York (November 2, 2012, 2:10 PM EDT) -- Teva Pharmaceutical Industries Ltd. said Thursday that it had received requests for documents from the U.S. Department of Justice in connection with a Foreign Corrupt Practices Act probe in Latin America, following a similar request from the U.S. Securities and Exchange Commission.
The Petah Tikva, Israel-based drugmaker said the DOJ made the informal solicitations on Oct. 10 and 26. These inquires came after a July 9 subpoena from the SEC seeking documents related to compliance with the FCPA in Latin America, the company said in a regulatory filing.
Teva, the largest generic drugmaker in the world, said it is cooperating with...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!